RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
IntroMedic Co Stock

IntroMedic Co Equity 2024

IntroMedic Co Equity

7.81 B KRW

Ticker

150840.KQ

ISIN

KR7150840007

In 2024, IntroMedic Co's equity was 7.81 B KRW, a -47.35% increase from the 14.84 B KRW equity in the previous year.

IntroMedic Co Aktienanalyse

What does IntroMedic Co do?

IntroMedic Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing IntroMedic Co's Equity

IntroMedic Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IntroMedic Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating IntroMedic Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

IntroMedic Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in IntroMedic Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about IntroMedic Co stock

What is the equity of IntroMedic Co this year?

IntroMedic Co has equity of 7.81 B KRW this year.

What was the equity of IntroMedic Co compared to the previous year?

The equity of IntroMedic Co has increased/decreased by -47.35% decreased compared to the previous year.

What impact does a high equity have on investors of IntroMedic Co?

A high equity is advantageous for investors of IntroMedic Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of IntroMedic Co?

A low equity can be a risk for investors of IntroMedic Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of IntroMedic Co affect the company?

An increase in equity of IntroMedic Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of IntroMedic Co affect the company?

A reduction in equity of IntroMedic Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of IntroMedic Co?

Some factors that can affect the equity of IntroMedic Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of IntroMedic Co so important for investors?

The equity of IntroMedic Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can IntroMedic Co take to change the equity?

To change equity, IntroMedic Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does IntroMedic Co pay?

Over the past 12 months, IntroMedic Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IntroMedic Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of IntroMedic Co?

The current dividend yield of IntroMedic Co is .

When does IntroMedic Co pay dividends?

IntroMedic Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IntroMedic Co?

IntroMedic Co paid dividends every year for the past 0 years.

What is the dividend of IntroMedic Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is IntroMedic Co located?

IntroMedic Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von IntroMedic Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IntroMedic Co from 11/16/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did IntroMedic Co pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of IntroMedic Co in the year 2023?

In the year 2023, IntroMedic Co distributed 0 KRW as dividends.

In which currency does IntroMedic Co pay out the dividend?

The dividends of IntroMedic Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IntroMedic Co

Our stock analysis for IntroMedic Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IntroMedic Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.